A Novel Model-Based Questionnaire Based on Low-Dose CT Screening Data for Chronic Obstructive Pulmonary Disease Diagnosis in Shimane, Japan

References

• Menezes AMB, Perez-Padilla R, Jardim JB, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875–1881. doi:10.1016/S0140-6736(05)67632-5
   PubMed Web of Science ®Google Scholar
• Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. doi:10.1016/S0140-6736(07)61377-4
   PubMed Web of Science ®Google Scholar
• Cigarette smoking and health. American Thoracic Society. Am J Respir Crit Care Med. 1996;153(2):861–865. doi:10.1164/ajrccm.153.2.8564146
   PubMedGoogle Scholar
• Terzikhan N, Verhamme KMC, Hofman A, Stricker BH, Brusselle GG, Lahousse L. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. Eur J Epidemiol. 2016;31(8):785–792. doi:10.1007/s10654-016-0132-z
   PubMed Web of Science ®Google Scholar
• Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology. 2004;9(4):458–465. doi:10.1111/j.1440-1843.2004.00637.x
   PubMed Web of Science ®Google Scholar
• Lundbäck B, Lindberg A, Lindström M, et al. Not 15 but 50% of smokers develop COPD?—Report from the obstructive lung disease in Northern Sweden Studies. Respir Med. 2003;97(2):115–122. doi:10.1053/rmed.2003.1446
   PubMed Web of Science ®Google Scholar
• Smith M, Wrobel J. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;871. doi:10.2147/COPD.S49621
   PubMed Web of Science ®Google Scholar
• Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data from the first national health and nutrition examination survey follow-up. Arch Intern Med. 2003;163(12):1475. doi:10.1001/archinte.163.12.1475
   PubMedGoogle Scholar
• Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380–386. doi:10.1183/09031936.00144208
   PubMed Web of Science ®Google Scholar
• Takahashi T, Ichinose M, Inoue H, Shirato K, Hattori T, Takishima T. Underdiagnosis and undertreatment of COPD in primary care settings. Respirology. 2003;8(4):504–508. doi:10.1046/j.1440-1843.2003.00501.x
   PubMed Web of Science ®Google Scholar
• Anthonisen N, Dik N, Manfreda J, Roos L. Spirometry and obstructive lung disease in Manitoba. Can Respir J. 2001;8(6):421–426. doi:10.1155/2001/572825
   PubMedGoogle Scholar
• Haroon SM, Jordan RE, O’Beirne-Elliman J, Adab P. Effectiveness of case finding strategies for COPD in primary care: a systematic review and meta-analysis. Npj Prim Care Respir Med. 2015;25(1):15056. doi:10.1038/npjpcrm.2015.56
   PubMedGoogle Scholar
• Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ. Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006;129(6):1531–1539. doi:10.1378/chest.129.6.1531
   PubMed Web of Science ®Google Scholar
• Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006;73(3):285–295. doi:10.1159/000090142
   PubMed Web of Science ®Google Scholar
• Kawayama T, Minakata Y, Matsunaga K, et al. Validation of symptom-based COPD questionnaires in Japanese subjects. Respirology. 2008;13(3):420–426. doi:10.1111/j.1440-1843.2008.01241.x
   PubMed Web of Science ®Google Scholar
• Stanley AJ, Hasan I, Crockett AJ, van Schayck OC, Zwar NA. Validation of the COPD diagnostic questionnaire in an Australian general practice cohort: a cross-sectional study. Prim Care Respir J. 2014;23(1):92–97. doi:10.4104/pcrj.2014.00015
   PubMedGoogle Scholar
• Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). J Chronic Obstr Pulm Dis. 2008;5(2):85–95. doi:10.1080/15412550801940721
   PubMed Web of Science ®Google Scholar
• Tsukuya G, Matsumoto K, Fukuyama S, et al. Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: the Hisayama study. Allergol Int. 2015;64(1):49–53. doi:10.1016/j.alit.2014.06.002
   PubMed Web of Science ®Google Scholar
• Inoue H, Tsukuya G, Samukawa T, et al. Comparison of the COPD population screener and international primary care airway group questionnaires in a general Japanese population: the Hisayama study. Int J Chron Obstruct Pulmon Dis. 2016;11:1903–1909. doi:10.2147/COPD.S110429
   PubMed Web of Science ®Google Scholar
• Samukawa T, Matsumoto K, Tsukuya G, et al. Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama study. Int J Chron Obstruct Pulmon Dis. 2017;12:1469–1481. doi:10.2147/COPD.S130453
   PubMed Web of Science ®Google Scholar
• The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. doi:10.1056/NEJMoa1102873
   PubMed Web of Science ®Google Scholar
• de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503–513. doi:10.1056/NEJMoa1911793
   PubMed Web of Science ®Google Scholar
• Nawa T, Fukui K, Nakayama T, et al. A population-based cohort study to evaluate the effectiveness of lung cancer screening using low-dose CT in Hitachi city, Japan. Jpn J Clin Oncol. 2019;49(2):130–136. doi:10.1093/jjco/hyy185
   PubMed Web of Science ®Google Scholar
• Nawa T. Low-dose CT screening for lung cancer reduced lung cancer mortality in Hitachi City. Int J Radiat Biol. 2019;95(10):1441–1446. doi:10.1080/09553002.2018.1511930
   PubMed Web of Science ®Google Scholar
• Mets OM, Schmidt M, Buckens CF, et al. Diagnosis of chronic obstructive pulmonary disease in lung cancer screening computed tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening. Respir Res. 2013;14(1):59. doi:10.1186/1465-9921-14-59
   PubMedGoogle Scholar
• Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–946. doi:10.1183/09031936.04.00014304
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.581
   PubMed Web of Science ®Google Scholar
• Schermer TRJ, Smeele IJM, Thoonen BPA, et al. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J. 2008;32(4):945–952. doi:10.1183/09031936.00170307
   PubMed Web of Science ®Google Scholar
• Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32(4):605–644. doi:10.1016/j.ccm.2011.09.001
   PubMed Web of Science ®Google Scholar
• Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet. 2017;389(10076):1323–1335. doi:10.1016/S0140-6736(16)32381-9
   PubMed Web of Science ®Google Scholar
• WHO. Global Health Observatory (GHO) data; overweight and obesity. Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/mean-bmi-(kg-m-)-(age-standardized-estimate). Accessed June 2, 2021.
   Google Scholar
• Kida K, Wakabayashi R, Mizuuchi T, Murata A. Screening for suspected chronic obstructive pulmonary disease with an eleven-item pre-interview questionnaire (11-Q). Intern Med. 2006;45(21):1201–1207. doi:10.2169/internalmedicine.45.1694
   PubMed Web of Science ®Google Scholar
• López Varela MV, Montes de Oca M, Rey A, et al. Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: the PUMA study: COPD case finding in primary care. Respirology. 2016;21(7):1227–1234. doi:10.1111/resp.12834
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–1440. doi:10.1378/chest.121.5.1434
   PubMed Web of Science ®Google Scholar
• Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33(4):379–387. doi:10.1016/S0009-9260(82)80301-2
   PubMed Web of Science ®Google Scholar
• Coxson HO, Mayo J, Lam S, Santyr G, Parraga G, Sin DD. New and current clinical imaging techniques to study chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(7):588–597. doi:10.1164/rccm.200901-0159PP
   PubMed Web of Science ®Google Scholar
• Gierada DS, Pilgram TK, Whiting BR, et al. Comparison of standard- and low-radiation-dose CT for quantification of emphysema. Am J Roentgenol. 2007;188(1):42–47. doi:10.2214/AJR.05.1498
   PubMed Web of Science ®Google Scholar
• Madani A, De Maertelaer V, Zanen J, Gevenois PA. Pulmonary emphysema: radiation dose and section thickness at multidetector CT quantification—comparison with macroscopic and microscopic morphometry. Radiology. 2007;243(1):250–257. doi:10.1148/radiol.2431060194
   PubMed Web of Science ®Google Scholar
• Zaporozhan J, Ley S, Weinheimer O, et al. Multi-detector CT of the chest: influence of dose onto quantitative evaluation of severe Emphysema A Simulation Study. J Comput Assist Tomogr. 2006;30(3):460–468. doi:10.1097/00004728-200605000-00018
   PubMed Web of Science ®Google Scholar
• Burrows B, Fletcher CM, Heard BE, Jones NL, Wootliff JS. The emphysematous and bronchial types of chronic airways obstruction. Lancet. 1966;287(7442):830–835. doi:10.1016/S0140-6736(66)90181-4
   Google Scholar
• Ogawa E, Nakano Y, Ohara T, et al. Body mass index in male patients with COPD: correlation with low attenuation areas on CT. Thorax. 2008;64(1):20–25. doi:10.1136/thx.2008.097543
   PubMed Web of Science ®Google Scholar
• Tatsumi K, Kasahara Y, Kurosu K, et al. Clinical phenotypes of COPD: results of a Japanese epidemiological survey. Respirology. 2004;9(3):331–336. doi:10.1111/j.1440-1843.2004.00611.x
   PubMed Web of Science ®Google Scholar